Dr. Krill-Jackson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UM Sylvester in Aventura
2801 NE 213th st
Aventura, FL 33180Phone+1 305-689-6500Fax+1 305-689-6565
Summary
- Dr. Elisa Krill-Jackson is a medical oncologist based in Miami, Florida, with a subspecialty focus on breast cancer. She completed her fellowship in Hematology and Medical Oncology at University of Miami/Jackson Health System and Tufts Medical Center and her residency in Internal Medicine at Brigham and Women's Hospital. She is a graduate of the University of Michigan Medical School. Dr. Krill Jackson is a specialist in breast oncology. She has been part of clinical trials on breast cancer treatment.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1994 - 1996
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1994
Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
University of Michigan Medical SchoolClass of 1990
Certifications & Licensure
FL State Medical License 1994 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACP) American College of Physicians, 2005
Clinical Trials
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Publications & Presentations
PubMed
- 48 citationsThe spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.Mohammad R. Akbari, T Donenberg, J. Lunn, D. Curling, T. Turnquest
Clinical Genetics. 2014-01-01 - 3 citationsLong-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis.Simon B. Zeichner, Ludimila Cavalcante, Gabriel P. Suciu, Ana L. Ruiz, Alicia Hirzel
Asian Pacific Journal of Cancer Prevention. 2014-01-01 - 24 citationsA randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.Adam Brufsky, Karen Hoelzer, Thaddeus Beck, Robert C. Whorf, Mark Keaton
Clinical Breast Cancer. 2011-08-01
Press Mentions
Breakthrough Treatment Helps Cancer Patients Keep Hair During ChemoOctober 28th, 2017
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
